Location: London, United Kingdom
CIK: 0001131399 · Show all filings
Period: Q4 2025 (Next →)
Filing Date: Feb 12, 2026
Total Value: $799M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 18,245,691 | $310M | 38.8% | $10.16 | 0.0% | SHS | Y95308105 |
| CRSP | CRISPR THERAPEUTICS AG | 3,220,627 | $169M | 21.1% | $59.89 | 0.0% | NAMEN AKT | H17182108 |
| BNTX | BIONTECH SE | 889,824 | $84.71M | 10.6% | $95.20 | — | SPONSORED ADS | 09075V102 |
| VIR | VIR BIOTECHNOLOGY INC | 8,550,954 | $51.56M | 6.5% | $5.95 | 0.0% | COM | 92764N102 |
| LYEL | LYELL IMMUNOPHARMA INC | 1,512,659 | $46.56M | 5.8% | $22.38 | 0.0% | COM NEW | 55083R203 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,333,333 | $46.09M | 5.8% | $31.88 | 0.0% | COM | 45166A102 |
| CYTK | CYTOKINETICS INC | 340,434 | $21.63M | 2.7% | $62.21 | 0.0% | COM NEW | 23282W605 |
| SPRO | SPERO THERAPEUTICS INC | 9,190,606 | $21.41M | 2.7% | $2.32 | 0.0% | COM | 84833T103 |
| FULC | FULCRUM THERAPEUTICS INC | 1,785,714 | $20.2M | 2.5% | $10.18 | 0.0% | COM | 359616109 |
| BCYC | BICYCLE THERAPEUTICS PLC | 1,529,561 | $10.83M | 1.4% | $7.08 | — | SPONSORED ADS | 088786108 |
| CVRX | CVRX INC | 1,007,583 | $7.154M | 0.9% | $9.13 | 0.0% | COM | 126638105 |
| NKTX | NKARTA INC | 3,150,732 | $5.829M | 0.7% | $2.00 | 0.0% | COM | 65487U108 |
| RGNX | REGENXBIO INC | 271,456 | $3.909M | 0.5% | $12.46 | 0.0% | COM | 75901B107 |
| SENS | SENSEONICS HLDGS INC | 10,856 | $59,925 | 0.0% | $6.96 | 0.0% | COM | 81727U303 |
| HBIO | HARVARD BIOSCIENCE INC | 11,151 | $7,458 | 0.0% | $0.59 | 0.0% | COM | 416906105 |